e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Impact of sleep-disordered breathing in other diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The association of obstructive sleep apnea with insulin resistance in obese Egyptians
M. Elhabashy (minoufia, Egypt), W. Shehab (minoufia, Egypt)
Source:
International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Session:
Impact of sleep-disordered breathing in other diseases
Session type:
Thematic Poster
Number:
851
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Elhabashy (minoufia, Egypt), W. Shehab (minoufia, Egypt). The association of obstructive sleep apnea with insulin resistance in obese Egyptians. 851
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Impact of obstructive sleep apnoea on insulin resistance in nonobese and obese children
Source: Eur Respir J 2016; 47: 1152-1161
Year: 2016
The inflammation and insulin resistance in obstructive sleep apnea
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Insulin resistance in obstructive sleep apnea patients
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Is obstructive sleep apnoea (OSA) associated with insulin resistance (IR) in severely obese adults?
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: 156-160
Year: 2003
Comparison of the association with sleep apnoea of obesity versus insulin resistance
Source: Eur Respir J 2015; 46: 1829-1832
Year: 2015
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Metabolic disturbances in patients with obstructive sleep apnoea syndrome
Source: Eur Respir Rev 2007; 16: 196-202
Year: 2007
The influence of obesity in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 295s
Year: 2002
Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007
Triglyceride-glucose index in non-diabetic, non-obese patients with obstructive sleep apnoea
Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea
Year: 2021
Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 113s
Year: 2004
In vitro
genioglossus function is different in obese and non-obese patients with obstructive sleep apnea
Source: Eur Respir J 2001; 18: Suppl. 33, 332s
Year: 2001
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Source: Eur Respir J 2007; 29: 720-727
Year: 2007
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 447s
Year: 2004
Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment
Source: Eur Respir J 2003; 22: 251-257
Year: 2003
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients
Source: Eur Respir J 2008; 31: 223-225
Year: 2008
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept